1. Home
  2. CERO vs RKDA Comparison

CERO vs RKDA Comparison

Compare CERO & RKDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • RKDA
  • Stock Information
  • Founded
  • CERO 2017
  • RKDA 2002
  • Country
  • CERO United States
  • RKDA United States
  • Employees
  • CERO N/A
  • RKDA N/A
  • Industry
  • CERO
  • RKDA Agricultural Chemicals
  • Sector
  • CERO
  • RKDA Industrials
  • Exchange
  • CERO Nasdaq
  • RKDA Nasdaq
  • Market Cap
  • CERO 5.6M
  • RKDA 5.8M
  • IPO Year
  • CERO N/A
  • RKDA 2015
  • Fundamental
  • Price
  • CERO $5.43
  • RKDA $3.46
  • Analyst Decision
  • CERO Strong Buy
  • RKDA
  • Analyst Count
  • CERO 2
  • RKDA 0
  • Target Price
  • CERO $45.00
  • RKDA N/A
  • AVG Volume (30 Days)
  • CERO 306.0K
  • RKDA 11.0K
  • Earning Date
  • CERO 08-22-2025
  • RKDA 11-11-2025
  • Dividend Yield
  • CERO N/A
  • RKDA N/A
  • EPS Growth
  • CERO N/A
  • RKDA N/A
  • EPS
  • CERO N/A
  • RKDA N/A
  • Revenue
  • CERO N/A
  • RKDA $5,407,000.00
  • Revenue This Year
  • CERO N/A
  • RKDA $21.31
  • Revenue Next Year
  • CERO N/A
  • RKDA $28.33
  • P/E Ratio
  • CERO N/A
  • RKDA N/A
  • Revenue Growth
  • CERO N/A
  • RKDA 23.79
  • 52 Week Low
  • CERO $4.27
  • RKDA $2.53
  • 52 Week High
  • CERO $895.40
  • RKDA $10.31
  • Technical
  • Relative Strength Index (RSI)
  • CERO 32.53
  • RKDA 40.87
  • Support Level
  • CERO $4.27
  • RKDA $3.03
  • Resistance Level
  • CERO $5.65
  • RKDA $3.82
  • Average True Range (ATR)
  • CERO 0.54
  • RKDA 0.23
  • MACD
  • CERO -0.17
  • RKDA 0.01
  • Stochastic Oscillator
  • CERO 31.12
  • RKDA 50.66

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a producer and marketer of plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, and others.

Share on Social Networks: